Staffan Encrantz's Insider Trades & SAST Disclosures
Staffan Encrantz's most recent trade in Sight Sciences Inc was a trade of 243,000 Common Stock done at an average price of $2.8 . Disclosure was reported to the exchange on March 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Staffan Encrantz.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sight Sciences Inc | Staffan Encrantz | Director, Ten Percent Owner | Other type of transaction at price $ 2.77 per share. | 10 Mar 2025 | 243,000 | 5,086,920 | - | 2.8 | 673,110 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director, Ten Percent Owner | Other type of transaction at price $ 2.71 per share. | 10 Mar 2025 | 150,000 | 4,843,920 | - | 2.7 | 406,500 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director, Ten Percent Owner | Other type of transaction at price $ 2.53 per share. | 10 Mar 2025 | 120,000 | 4,693,920 | - | 2.5 | 303,600 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.73 per share. | 21 Nov 2024 | 551,802 | 4,573,920 | - | 3.7 | 2,058,221 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.73 per share. | 21 Nov 2024 | 551,802 | 632,456 | - | 3.7 | 2,058,221 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 17,366 | 1,029,516 | - | 0 | Common Stock | |
| Sight Sciences Inc | Staffan Encrantz | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 15,094 | 11,940 | - | 0 | Common Stock | |
| Sight Sciences Inc | Staffan Encrantz | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 11,940 | 11,940 | - | 0 | Common Stock | |
| Sight Sciences Inc | Staffan Encrantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 11,940 | 11,940 | - | - | Restricted Stock Units | |
| Sight Sciences Inc | Staffan Encrantz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.20 per share. | 13 May 2022 | 300,000 | 301,802 | - | 8.2 | 2,460,000 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.49 per share. | 13 May 2022 | 250,000 | 551,802 | - | 8.5 | 2,123,725 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.98 per share. | 13 May 2022 | 1,802 | 1,802 | - | 8.0 | 14,382 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director | Purchase of securities on an exchange or from another person at price $ 22.36 per share. | 29 Nov 2021 | 123,931 | 3,959,159 | - | 22.4 | 2,771,097 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director | Purchase of securities on an exchange or from another person at price $ 20.40 per share. | 29 Nov 2021 | 94,969 | 3,750,676 | - | 20.4 | 1,937,368 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director | Purchase of securities on an exchange or from another person at price $ 18.84 per share. | 29 Nov 2021 | 84,254 | 3,581,372 | - | 18.8 | 1,587,345 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director | Purchase of securities on an exchange or from another person at price $ 19.44 per share. | 29 Nov 2021 | 72,135 | 3,655,707 | - | 19.4 | 1,402,304 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director | Purchase of securities on an exchange or from another person at price $ 22.92 per share. | 29 Nov 2021 | 62,959 | 4,022,118 | - | 22.9 | 1,443,020 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director | Purchase of securities on an exchange or from another person at price $ 20.96 per share. | 29 Nov 2021 | 56,836 | 3,807,512 | - | 21.0 | 1,191,283 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director | Purchase of securities on an exchange or from another person at price $ 21.43 per share. | 29 Nov 2021 | 27,716 | 3,835,228 | - | 21.4 | 593,954 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director | Purchase of securities on an exchange or from another person at price $ 19.06 per share. | 29 Nov 2021 | 2,200 | 3,583,572 | - | 19.1 | 41,932 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director | Purchase of securities on an exchange or from another person at price $ 24.00 per share. | 18 Oct 2021 | 527,048 | 3,497,118 | - | 24 | 12,649,152 | Common Stock |
| Sight Sciences Inc | Staffan Encrantz | Director | 19 Jul 2021 | 2,970,070 | 2,970,070 | - | 0 | Common Stock | ||
| Sight Sciences Inc | Staffan Encrantz | Director | 19 Jul 2021 | 724,637 | 0 | - | - | Series A Redeemable Convertible Preferred Stock | ||
| Sight Sciences Inc | Staffan Encrantz | Director | 19 Jul 2021 | 661,653 | 0 | - | - | Series C Redeemable Convertible Preferred Stock | ||
| Sight Sciences Inc | Staffan Encrantz | Director | 19 Jul 2021 | 632,456 | 632,456 | - | 0 | Common Stock | ||
| Sight Sciences Inc | Staffan Encrantz | Director | 19 Jul 2021 | 316,228 | 0 | - | - | Series C Redeemable Convertible Preferred Stock | ||
| Sight Sciences Inc | Staffan Encrantz | Director | 19 Jul 2021 | 98,745 | 0 | - | - | Series B Redeemable Convertible Preferred Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges